Navigation Links
Germany Hosts World Leading Medical Industry Fair
Date:11/13/2007

5. This fact has meant a growing sophistication and commercialization of healthcare and homecare products and services, with positive returns for investors.

"We look forward to MEDICA as it is both one of the world's biggest gatherings of medical devices experts and a chance to educate potential investors about the many advantages that Germany offers pioneering companies," notes Dr. Nicola Henneberg, Senior Manager for Medical Devices at Invest in Germany.

Invest in Germany is the inward investment promotion agency of the Federal Republic of Germany. Its mandate is to promote Germany as an attractive business location. Invest in Germany provides investors with comprehensive support from site selection to the implementa-tion of investment decisions.

Media Contact:

Eva Henkel

Invest in Germany

Phone: +49-30-200099-173

Fax: +49-30-200099-111

Email: henkel@invest-in-germany.com

http://www.invest-in-germany.com


'/>"/>
SOURCE Invest in Germany
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
2. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
3. Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium
4. Pharsight Hosts Fourth Annual PKS User Group Meeting
5. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
6. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
7. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
8. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
9. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
10. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
11. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... "Global Human Albumin Industry Report 2014" report to ... Industry Report 2014 is a professional and in-depth study ... industry. The report provides a basic overview ... chain structure. The human albumin market analysis is provided ...
(Date:9/18/2014)...  U.S. biotech company Kultevat has strengthened ... technology developed by the Donald Danforth Plant Science ... for applications in production of natural rubber in ... developed under the direction of Roger Beachy , ... of the Danforth Plant Science Center, and is used ...
(Date:9/18/2014)... 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY ... but separate underwritten offerings of 10,000,000 shares of its ... $2.00 per share, for expected gross proceeds of $20 ... Preferred Stock at a price to the public of ... million. Each share of Series A Convertible Preferred Stock ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 OMICS ... the globe to participate in the ‘Open Access ... articles to OMICS Group Pharma Journals ... one of the fastest emerging Sciences, accelerating with ... healthcare services across the globe. The industry is ...
Breaking Biology Technology:Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3Kultevat obtains license of gene switch technology 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3Pharma and Omics Journals to Address Global Challenges during Open Access Week 2Pharma and Omics Journals to Address Global Challenges during Open Access Week 3
... Stereotaxis, Inc. (Nasdaq:, STXS ) announced today ... quarter and full year ended December 31, 2008, on ... will host a conference call and,webcast on Thursday, February ... Company,s fourth quarter results and current corporate developments. The,dial-in ...
... Pharmaceuticals, Inc., a privately held drug development company, ... New Drug (IND) application with the U.S. Food ... anticancer compound. GGTI-2418 is a synthetic peptidomimetic ... to induce apoptosis by downregulating several pivotal oncogenic ...
... Ltd. (Nasdaq: XTLB , TASE: XTL) today ... a letter from a shareholder who,owns more than 5% ... an extraordinary shareholders, meeting (EGM) of the Company as,soon ... , 1. that Boaz Shweiger ...
Cached Biology Technology:Stereotaxis Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call 2Tigris Pharmaceuticals Files IND Application for GGTI-2418 2Tigris Pharmaceuticals Files IND Application for GGTI-2418 3Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter 2
(Date:9/18/2014)... Worcester, Mass. A novel robotic system that can ... currently being tested as part of a biomedical research ... with the aim of determining if the robot, in ... biopsies faster, more accurate, less costly, and less discomforting ... potential to deliver prostate cancer therapies with greater precision. ...
(Date:9/18/2014)... to acquire and creatively manipulate spoken language is unique ... past 6 million years of human evolution to make ... best candidate gene we now have," says Wolfgang Enard, ... his efforts to understand the molecular biological basis of ... The results of his latest study, undertaken in collaboration ...
(Date:9/18/2014)... seem to be cheerful, happy-go-lucky characters, so you might ... life. , In fact some dogs are distinctly ... Sydney shows. , "This research is exciting because ... objectively and non-invasively. It offers researchers and dog owners ... that changes," said Dr Melissa Starling, from the Faculty ...
Breaking Biology News(10 mins):Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5Language evolution: Quicker on the uptake 2Language evolution: Quicker on the uptake 3Dogs can be pessimists too 2Dogs can be pessimists too 3
... in French . , Montreal, December ... from a blueprint, Stephen Michnick is helping the scientific ... Universit de Montral biochemistry professor and Canada Research Chair ... that have enabled him to examine how proteins interact ...
... 16, 2008) Researchers from Virginia Commonwealth University have identified ... and suppress a key protein that is overexpressed in 90 ... to an effective gene therapy for cancer. According ... the Department of Human and Molecular Genetics and director of ...
... European Society of Oncological Urology (ESOU) will be ... January 2009, with organisers presenting the latest updates ... the fast-changing developments in onco-urological treatment strategies, the ... and researchers the opportunity to explore the various ...
Cached Biology News:Call Stephen Michnick a gene grammarian 2Researchers identify new anti-tumor gene 26th ESOU Meeting 2
...
... Protein, 1. Based on the methodology ... kit gives essentially colorless backgrounds in ... Protein provides convenient, reproducible and sensitive ... in less than two hours.The visualization ...
Mouse monoclonal [IFR0104] to Salmonella enteriditis ( Abpromise for all tested applications)....
Cyno macaque plasma and serum - various quantities available...
Biology Products: